Will Ashworth

Will Ashworth

InvestorPlace Contributor

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

An Activist Investor Unwisely Wants to Cancel Canopy Growth/Acreage Deal

By Will Ashworth, InvestorPlace Contributor

Activist investor Marcato owns a measly 2.7% of Acreage and is trying to stop the CGC deal. It won’t hurt CGC stock. Just ACRGF.

Could Fintech Lift Infosys Stock to $20?

By Will Ashworth, InvestorPlace Contributor

The INFY transformation continues to gain traction. Could fintech be what drives INFY stock higher in coming years?

7 Stocks to Buy From the T. Rowe Price Health Sciences Fund

By Will Ashworth, InvestorPlace Contributor

One of the best mutual funds last year was the T. Rowe Price Health Sciences Fund. Here are 7 healthcare stocks to buy from its holdings.

CVS’ Tweaking of Its Stores Is Good for CVS Stock

By Will Ashworth, InvestorPlace Contributor

CVS Health announced strong results. The news included the closing of 46 of its stores. If you own CVS stock, here’s why that’s a good thing.   

3 Things Alibaba Must Do to Get BABA Stock to $250

By Will Ashworth, InvestorPlace Contributor

In the three months ended December 31, its international commerce sales (retail and wholesale) were $1.2 billion or 7.8% of the company’s total commerce revenues. In the third quarter, its international retail commerce sales grew by 23% year over year while its international wholesale commerce sales rose by 31%, albeit representing a smaller dollar value than retail.

Load More